Exploring Knowledge Graphs for COVID-19 Drug Discovery

Today, there are only a few therapies approved to treat COVID-19, but while novel therapies can take decades and billions of dollars to develop, are there opportunities to repurpose existing drugs for new therapies? Our latest whitepaper showcases how CAS Knowledge Graphs reveal new connections and insights that identify drugs to potentially repurpose.

Drug repurposing is critical for faster development of therapies. However, assembling all the critical information and connections around new proteins, viruses, targets, pathways, and clinical information can be challenging. This demonstrates how CAS Knowledge Graphs can identify top clinical candidates to repurpose for COVID-19 therapies.